1-Butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide

CAS : 27262-47-1

Ref. 3D-FB19357

Informations sur le produit

• Nom: 1-Butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide
• Synonymes: (S)-(-)-BupivacaineL-(-)-BupivacaineLevobupivacaine, (-)-(S)-Bupivacaine, (-)-Bupivacaine, (2S)-1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide, (2S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide, 2',6'-Pipecoloxylidide, 1-butyl-, (-)-, 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (S)-, 2′,6′-Pipecoloxylidide, 1-butyl-, (-)-, <span class="text-smallcaps">L</span>-(-)-Bupivacaine, Chirocain, L-(-)-Bupivacaine, Levobupivacaine, 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)-

Description

Ropivacaine is a local anaesthetic of the amino ester group that is used to provide relief from pain caused by surgery or other medical procedures. It is a potent inhibitor of the enzyme activity of cholinesterases, which are enzymes responsible for the degradation of acetylcholine. Ropivacaine also inhibits the activity of cardiac Na+/K+ ATPase and Na+-Ca2+ exchanger, thereby reducing the excitability and contractility of heart muscle. This drug has shown pharmacokinetic properties in maternal blood that are similar to those observed in plasma, indicating that it can cross the placenta. Ropivacaine has been shown to have bactericidal effects against bacterial strains such as Escherichia coli and Staphylococcus aureus. In addition, ropivacaine has been shown to inhibit colorectal adenocarcinoma cells in vitro and in vivo. Levobupivacaine

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 288.43 g/mol
• Formule: C₁₈H₂₈N₂O
• Degré de pureté: Min. 95%
• Couleur/Forme: White/Off-White Solid